4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000891293-17-000107
CIK 0000891293other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:42 PM ET
Size
5.4 KB
Accession
0000891293-17-000107
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-09-29+350,000→ 350,000 totalExercise: $3.19Exp: 2027-09-29→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in six equal semi-annual installments over a three-year period beginning September 29, 2017 subject to continued employment by CTIC through the applicable vesting dates.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:42 PM ET
- Size
- 5.4 KB